Trial Profile
Dienogest Versus Luteal Phase Fluoxetine in the Management of Premenstrual Syndrome: A Randomized Double Blind Placebo Controlled Trial
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2022
Price :
$35
*
At a glance
- Drugs Dienogest (Primary) ; Fluoxetine
- Indications Premenstrual syndrome
- Focus Therapeutic Use
- 30 Nov 2020 Planned End Date changed from 1 Dec 2017 to 1 Dec 2021.
- 30 Nov 2020 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2021.
- 20 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.